Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Denosumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Denosumab 60mg/1ml inj pre-filled syringes
0606020Z0AAAAAA
|
Denosumab | Denosumab | Endocrine System | 21,768 |
|
Prolia 60mg/1ml solution for injection pre-filled syringes
0606020Z0BBAAAA
|
Prolia | Denosumab | Endocrine System | 11,443 |
|
Xgeva 120mg/1.7ml solution for injection vials
0606020Z0BCAAAB
|
Xgeva | Denosumab | Endocrine System | 828 |
|
Denosumab 120mg/1.7ml solution for injection vials
0606020Z0AAABAB
|
Denosumab | Denosumab | Endocrine System | 664 |
|
Xgeva 120mg/1ml solution for injection pre-filled syringes
0606020Z0BCABAC
|
Xgeva | Denosumab | Endocrine System | 68 |
|
Denosumab 120mg/1ml inj pre-filled syringes
0606020Z0AAACAC
|
Denosumab | Denosumab | Endocrine System | 67 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.